The relation of urinary cotinine measurements to tobacco consumption in smokers and to exposure to other people's smoke in non-smokers was studied in 49 smokers and 184 reported non-smokers attending a health screening centre. The median urinary cotinine concentration was 1623 ng/ml* in the smokers and 6-1 ng/ml in the non- The potential health risks to non-smokers of other people's tobacco smoke have received much attention. Major reports on such "passive smoking" have been compiled by national research organisations in several countries, including the United States,' Australia,2 and the United Kingdom,3 and the issue is of concern to politicians and the general public. A review of the epidemiological studies of the effect of passive smoking on lung cancer risk4 concluded that the risk might be 30% higher in non-smokers living with smokers than in non-smokers living with non-smokers.
smokers. In smokers the average urinary cotinine concentration increased with reported habitual cigarette consumption; in non-smokers it increased with the reported total seven day duration of exposure to other people's tobacco smoke. Cotinine concentrations were approximately three times higher in non-smokers living with a spouse or partner who was a smoker than in those living with a non-smoker; their reported duration of exposure to tobacco smoke was also three times higher. Nonsmoking subjects who were exposed to any tobacco smoke and who lived with a smoker reported 70% of their exposure to be at home (56% for men and 86% for women); the men reported more exposure at work than non-smoking men who lived with a non-smoker. This study confirms the relation of urinary cotinine to stated tobacco smoke exposure in both smokers and non-smokers and further validates the use of information on the smoking habits of the spouse or partner as a measure of tobacco smoke exposure in epidemiological studies of nonsmokers.
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The potential health risks to non-smokers of other people's tobacco smoke have received much attention. Major reports on such "passive smoking" have been compiled by national research organisations in several countries, including the United States,' Australia,2 and the United Kingdom,3 and the issue is of concern to politicians and the general public. A review of the epidemiological studies of the effect of passive smoking on lung cancer risk4 concluded that the risk might be 30% higher in non-smokers living with smokers than in non-smokers living with non-smokers.
One problem with epidemiological studies of passive smoking is the lack of a good measure of exposure. Recall of habitual or recent exposure to environmental tobacco smoke may be imprecise and inaccurate and the measure used in most epidemiological studies, whether or not the subject lives with a smoker, may appear to be crude. It has, however, been validated by measurements of urinary cotinine, a metabolite of nicotine; in non-smoking men who reported exposure to other people's tobacco smoke and unexposed non-smoking men who reported no exposure, urinary cotinine concentration was a sensitive and specific marker of exposure to other people's tobacco smoke.56
The present study was designed (1) to obtain cotinine data on women as well as men; (2) to determine the places where non-smokers are exposed to other people's tobacco smoke; and (3) to check earlier results on the validity of using the smoking habit (smoking versus non-smoking) of the person a nonsmoker lives with as a measure of the exposure to other people's tobacco smoke.
Methods

SUBJECTS
We studied 233 men and women attending the BUPA Medical Centre in London on specific days. Smokers completed a questionnaire on their smoking habits and non-smokers on their exposure to other people's smoke. Nonsmokers were asked if they had been exposed to other people's tobacco smoke during the past seven days (including the day of attendance); if they had, they were asked about duration (how long the smoke could be smelt) and places of exposure.
COTININE ASSAY
A urine sample was obtained and frozen at -40°C until analysis. Urinary cotinine was measured by means of a radioimmunoassay7 modified to improve the reproducibility for measurements in urine samples. Bovine serum albumin 0.10% (Sigma Chemical Company, Dorset) was added to the assay buffer and a second antibody used to separate the bound fraction (ILS, London). Samples from smokers were diluted 20 fold and a 0-01 ml sample assayed. To increase the sensitivity of the assay to detect cotinine in the urine of nonsmokers, the volume of the sample to be assayed was increased to 0-1 ml. To check that accuracy was maintained between the different versions of the assay, a urine pool from samples *Conversion to SI units for cotinine: 1 ng/ml=5 68 nmol/l. Urinary cotinine concentrations in smokers were approximately normally distributed, whereas in non-smokers a logarithmic transformation of the cotinine concentrations was necessary to achieve approximate normality. Thus statistical analyses for non-smokers used transformed data, but results have been converted back to the untransformed scale for presentation. Since cotinine has a half life of about one day, we also performed an analysis that down weighted exposures reported several days before by a factor of 0-5 for each day between the exposure and the day the urine sample was collected. Adjustment for creatinine concentration was performed by linear regression of cotinine in smokers, or log cotinine in non-smokers, on creatinine.8 All the p values presented are 2-sided.
Results
The 49 smokers recruited had an average age of 42 (SD 1 1) years, and an average age at which they had started to smoke regularly of 19 (4) years. Three subjects currently smoked cigars only and one subject smoked filter cigarettes and cigars. The remaining 45 subjects smoked only filter cigarettes. Of the 184 non-smokers, 74 were ex-smokers and 110 reported that they were lifelong non-smokers. The average age of the non-smokers was 46 ( 11) years.
The median urinary cotinine concentration was 1623 ng/ml in the smokers and 6-1 ng/ml in the non-smokers. Median values for smokers and non-smokers were similar for men and women (table 1) There was no significant difference in the geometric mean cotinine concentrations between ex-smokers (5-6 ng/ml) and reported lifelong non-smokers (4-6 ng/ml, p > 0-2). Of the non-smokers, 53 reported no exposure to tobacco smoke in the preceding week; they had a geometric mean cotinine concentration of 3-7 ng/ml, compared with 5-7 ng/ml in the other 131 non-smokers. Further subdivision according to the extent of reported exposure is shown in table 2. Increases in geometric mean cotinine concentr4atiws were observed only in the upper two qumtiles of exposure duration (average duratiuns-1 and 34 hours). A linear regression of log cotinine concentration on duration of exposure (with the subject who reported 101 hours of exposure omitted) showed that cotinine concentrations increased by an average of 44% (95% confidence interval 23-67%, p < 0-001) for each increase of 10 hours in reported exposure (fig 3) . The correlation between log urinary cotinine concentration and reported total duration of exposure was 0-33. When the reported exposures were weighted to adjust for cotinine half life the correlation 15, 6-9, 7-2, 9-4, and 27 ng/ml; the arithmetic mean for the 1st quintile group excluding the two subjects with cotinine values greater than 100 ng/ml (see text) was 5-6 ng/ml. Reported total seven day exposure (hours) Figure 3 Urinary cotinine concentrations in relation to reported total seven day exposure to tobacco smoke among 183 non-smokers (the subject with 101 hours' reported exposure and a urinary cotinine concentration of 328 ng/ml is excluded).
between log cotinine concentration and weigh- Table 4 Sources of reported exposure in 131 non-smokers exposed to other people's tobacco smoke within the past seven days according to the current smoking habit of the person with whom the subject lives* In epidemiological studies non-smokers living with smokers have been observed to have a 30 o greater lung cancer risk than non-smokers living with non-smokers. 4 The threefold difference in urinary cotinine concentrations between these groups can be used to estimate that non-smokers living with smokers have a 53% greater risk of lung cancer than non-smokers who are completely unexposed to environmental tobacco smoke.4
In our present study non-smoking men who lived with a smoker not only reported greater exposure to tobacco smoke in the home than did non-smoking men not living with a smoker but also a greater exposure at work. This was similar to our previous result6 and explains why a measure of exposure based on the smoking habits of the spouse or partner may be a more sensitive indicator of environmental tobacco smoke exposure than it might at first appear. The finding was not, however, seen among the women in this study, perhaps because of the small numbers.
The overall relation between cotinine concentrations and reported duration of tobacco smoke exposure in the non-smokers was significant, though the correlation was not strong. This may have been due to variability in urinary cotinine concentrations (due to the arbitrary time of urine collection, with no fixed relation to recent exposure) and in the reporting of exposure (due to failure of accurate recall of duration and the lack of any measure of the intensity of exposure). The down weighting of durations of exposure further away from the time of urine collection was expected to increase the correlation with cotinine concentrations. That it did not do so was unexpected, but may have been due to the combination of a consistency between the exposures reported for the same individuals on different days (as had been found in other circumstances10) and the play of chance, resulting in particular from the large amount of variability in the measurements.
The overlap in the distributions of urinary cotinine concentrations in smokers and nonsmokers was greater than the overlap we found in our previous study in men.' This could be due to the fact that some women smoked only a few cigarettes each day and had not smoked on the day of the urine collection. Three subjects who said they were non-smokers had urinary cotinine concentrations above 100 ng/ml. Two of them reported no tobacco smoke exposure and one a total seven day exposure of 101 hours. It seems likely that the first two subjects failed to report either very extensive passive exposure or occasional active smoking. The third subject's cotinine concentration is plausible if the reported exposure is considered correct. On the basis of the distribution of cotinine concentrations none of the reported non-smokers could be considered a typical smoker. The lack of typical smokers misreporting themselves as non-smokers strengthens the argument that the observed excess lung cancer risk in epidemiological studies is unlikely to be due to the misclassification of smokers as non-smokers.4
The hypothesis'1 that the excess lung cancer risk observed in the epidemiological studies could be completely explained by such misclassification required that 1.4% of self reported never smokers were regular current smokers and that 1-1 % were occasional current smokers. The information provided by the present study is important therefore as it strongly suggests that this hypothesis is untenable.
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